ALK and angioimmunoblastic T-cell lymphoma: Patients with ALK+ ALCL seems to have higher incidence of CNS relapse compared with AITL, although not a statistically significant difference possibly due to the small number of cases (HR: 8.2, 95%CI: 0.9–73.5, p = 0.060).